2.52
price up icon1.82%   0.05
 
loading
Schlusskurs vom Vortag:
$2.47
Offen:
$2.45
24-Stunden-Volumen:
2.23M
Relative Volume:
0.35
Marktkapitalisierung:
$2.55B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.5979
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-12.98%
1M Leistung:
-7.20%
6M Leistung:
-29.15%
1J Leistung:
-52.28%
1-Tages-Spanne:
Value
$2.405
$2.56
1-Wochen-Bereich:
Value
$2.39
$3.03
52-Wochen-Spanne:
Value
$2.28
$10.53

Immunitybio Inc Stock (IBRX) Company Profile

Name
Firmenname
Immunitybio Inc
Name
Telefon
(844) 696-5235
Name
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
Mitarbeiter
680
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
IBRX's Discussions on Twitter

Vergleichen Sie IBRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBRX
Immunitybio Inc
2.52 2.55B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
480.71 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.79 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
603.29 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.08 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
231.54 26.16B 3.81B -644.79M -669.77M -6.24

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-06 Eingeleitet H.C. Wainwright Buy
2025-01-10 Eingeleitet BTIG Research Buy
2023-05-12 Herabstufung Piper Sandler Overweight → Neutral
2022-08-03 Eingeleitet Jefferies Buy

Immunitybio Inc Aktie (IBRX) Neueste Nachrichten

pulisher
Apr 17, 2025

Why ImmunityBio, Inc. (IBRX) Declined on Wednesday - Yahoo Finance

Apr 17, 2025
pulisher
Apr 16, 2025

Economic Uncertainties Batter Trading in These 10 Firms - Insider Monkey

Apr 16, 2025
pulisher
Apr 15, 2025

ImmunityBio sees Q1 sales surge, submits FDA applications By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio Completes FDA License Application Submissions - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Immunitybio Announces FDA Submissions Of Supplemental BLA For Nmibc Papillary Disease And For Expanded Access Of Anktiva®To Treat Lymphopenia - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio sees Q1 sales surge, submits FDA applications - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Why ImmunityBio Inc. (IBRX) Skyrocketed On Monday? - Insider Monkey

Apr 15, 2025
pulisher
Apr 14, 2025

Is ImmunityBio Stock Heading Upwards? - timothysykes.com

Apr 14, 2025
pulisher
Apr 09, 2025

ImmunityBio settles securities class action lawsuit for $10.5 million - Claim Depot

Apr 09, 2025
pulisher
Apr 09, 2025

ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

Why ImmunityBio Inc. (IBRX) Went Down On Tuesday? - Insider Monkey

Apr 09, 2025
pulisher
Apr 08, 2025

ImmunityBio secures $75 million in direct offering - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio secures $75 million in direct offering By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

SEC Form 424B5 filed by ImmunityBio Inc. - Quantisnow

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Stock: What’s Driving the Market? - timothysykes.com

Apr 08, 2025
pulisher
Apr 08, 2025

Rallybio ends development in rare disorder; ImmunityBio raises $75M - Endpoints News

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Launches $75 Million Registered Direct Offering - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio (IBRX) Secures $75 Million in Direct Offering - GuruFocus

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio raises $75 million in equity financing - MSN

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Secures $75 Million in Direct Offering - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor - Business Wire

Apr 08, 2025
pulisher
Apr 07, 2025

IMMUNITYBIO, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch - BioSpace

Apr 07, 2025
pulisher
Apr 04, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, - GlobeNewswire

Apr 04, 2025
pulisher
Apr 04, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors - TradingView

Apr 04, 2025
pulisher
Apr 03, 2025

ImmunityBio: Taking Care Of Business (NASDAQ:IBRX) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 01, 2025

ImmunityBio and Beigene to run Phase 3 of Anktiva plus PD-1 in NSCLC - PPF Group

Apr 01, 2025
pulisher
Mar 29, 2025

Why ImmunityBio Inc. (IBRX) Went Up Last Week? - Yahoo Finance

Mar 29, 2025
pulisher
Mar 28, 2025

Is ImmunityBio, Inc. Stock a Buy Right Now? - timothysykes.com

Mar 28, 2025
pulisher
Mar 27, 2025

ImmunityBio’s Recent Surge: What’s Behind It? - timothysykes.com

Mar 27, 2025
pulisher
Mar 26, 2025

ImmunityBio to Host Investor Day - BioSpace

Mar 26, 2025
pulisher
Mar 25, 2025

Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates - EIN News

Mar 24, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd - Law360

Mar 18, 2025
pulisher
Mar 18, 2025

ImmunityBio $10.5 Million Settlement Over Record Selloff Gets OK - Bloomberg Law News

Mar 18, 2025
pulisher
Mar 18, 2025

From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines - Fast Company

Mar 18, 2025
pulisher
Mar 17, 2025

ImmunityBio ($IBRX) Is Paying a $10.5M Settlement to Investors — Here’s How to Get Your Share - TradingView

Mar 17, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock By Investing.com - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock - Investing.com

Mar 14, 2025

Finanzdaten der Immunitybio Inc-Aktie (IBRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.85
price down icon 0.77%
$71.22
price down icon 2.53%
$32.51
price up icon 0.11%
$24.83
price down icon 0.47%
$97.38
price down icon 1.48%
biotechnology ONC
$231.14
price up icon 0.63%
Kapitalisierung:     |  Volumen (24h):